☰

Stephen K. Gruschkus, Ph.D. - Publications

Affiliations: 
2009 Epidemiology & Disease Control The University of Texas School of Public Health 
Area:
Epidemiology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Ballhausen A, Urias E, Gruschkus SK, Williams M, Glover MS, Qin Y, Gombos DS, Patel SP. Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients. Cancers. 13. PMID 34209210 DOI: 10.3390/cancers13133292  0.305
2021 Nieto Y, Gruschkus S, Valdez BC, Jones RB, Anderlini P, Hosing C, Popat U, Qazilbash M, Kebriaei P, Alousi A, Saini N, Srour S, Rezvani K, Ramdial J, Barnett M, et al. Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis. Haematologica. PMID 33951890 DOI: 10.3324/haematol.2021.278311  0.33
2013 Shah M, Winfree KB, Peterson P, Gruschkus SK, Eaddy M, Green MR. Cost effectiveness of first-line pemetrexed plus platinum compared with other regimens in the treatment of patients with nonsquamous non-small cell lung cancer in the US outpatient setting. Lung Cancer (Amsterdam, Netherlands). 82: 121-7. PMID 23973203 DOI: 10.1016/j.lungcan.2013.07.021  0.359
2011 Nadler E, Yu E, Ravelo A, Sing A, Forsyth M, Gruschkus S. Bevacizumab treatment to progression after chemotherapy: outcomes from a U.S. community practice network. The Oncologist. 16: 486-96. PMID 21441299 DOI: 10.1634/theoncologist.2010-0287  0.389
2011 Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Cost-effectiveness of white blood cell growth factor use among a large nationwide cohort of elderly non-Hodgkin's lymphoma patients treated with chemotherapy. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 253-62. PMID 21402294 DOI: 10.1016/J.Jval.2010.09.010  0.553
2010 Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapy. Journal of the American Geriatrics Society. 58: 1885-95. PMID 20840455 DOI: 10.1111/J.1532-5415.2010.03081.X  0.534
2010 Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma. Cancer. 116: 5279-89. PMID 20665502 DOI: 10.1002/Cncr.25525  0.608
2010 Gruschkus SK, Lairson DR, Dunn JK, Risser JMH, Du X. Abstract B129: Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly non‐Hodgkin's lymphoma patients Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B129  0.624
2010 Gruschkus S, Lairson D, Dunn J, Risser J, Du X. PCN76 COST-EFFECTIVENESS OF WHITE BLOOD CELL GROWTH FACTOR USE AMONG ELDERLY NON-HODGKIN'S LYMPHOMA PATIENTS TREATED WITH CHEMOTHERAPY Value in Health. 13: A38. DOI: 10.1016/S1098-3015(10)72165-3  0.592
2010 Gruschkus S, Lairson D, Dunn J, Risser J, Du X. PCN1 USE OF WHITE BLOOD CELL GROWTH FACTORS AND RISK OF ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROMES AMONG ELDERLY NON-HODGKIN'S LYMPHOMA PATIENTS Value in Health. 13: A23. DOI: 10.1016/S1098-3015(10)72092-1  0.584
Show low-probability matches.